Frederick Ehrsam IIIiMinor difference of -1,375 shares. Difference is under 0.5% of holdings. Director | 28.35M | −371K | 27.98M | 99% |
Vesting, gifts, unvested awards and holding lines for Frederick Ehrsam III+1.1Kshares vested or exercised 0gifted (net of own trusts) 1.1K → 2.3Kunvested awards, start → end Reconciliation: minor difference of -1,375 shares. Difference is under 0.5% of holdings. |
Brian ArmstrongiMinor difference of -25,000 shares. Difference is under 0.5% of holdings. Additional holdings last reported more than 3 years ago are shown separately and excluded from totals. Chairman and CEO, Director | 25.74M | −275K | 25.64M | 99.6% |
Vesting, gifts, unvested awards and holding lines for Brian Armstrong+200Kshares vested or exercised 0gifted (net of own trusts) none reportedunvested awards, start → end - Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.
Additional holdings last reported Jul 5, 2023, not confirmed since: 950,490 shares. Not included in any total or percentage on this page. Stock options (not counted as shares): Estimate: options held × ($198.00 − strike price), using the most recent insider trade price on Form 4 (Oct 2, 2026), not a market close. Reconciliation: minor difference of -25,000 shares. Difference is under 0.5% of holdings. |
Marc Andreessen!Most of this insider's holdings were last confirmed in 2021. Confirmed in the last three years: 3,374,772 shares. Not confirmed since: 11,754,883 shares, left out of this row. "Still held" is not shown because it would cover only the smaller, confirmed part. Director | 3.41M | −41K | 3.37M | see note |
Vesting, gifts, unvested awards and holding lines for Marc Andreessen+1.1Kshares vested or exercised 0gifted (net of own trusts) 1.1K → 2.3Kunvested awards, start → end - Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.
Additional holdings last reported Dec 20, 2021, not confirmed since: 11,754,883 shares. Not included in any total or percentage on this page. - Andreessen Horowitz Fund III, L.P, Class A Common Stock: 10,864,179 shares, last reported Dec 20, 2021
- AH Parallel Fund III, L.P, Class A Common Stock: 890,493 shares, last reported Dec 20, 2021
- a16z Seed-III, LLC, Class A Common Stock: 211 shares, last reported Dec 20, 2021
|
Emilie ChoiiMinor difference of 47 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer). Additional holdings last reported more than 3 years ago are shown separately and excluded from totals. President & COO | 318K | −100K | 699K | not meaningful |
Vesting, gifts, unvested awards and holding lines for Emilie Choi+754Kshares vested or exercised 0gifted (net of own trusts) −374Kwithheld by the company for taxes 271K → 671Kunvested awards, start → end - Additional holdings last reported more than 3 years ago are shown separately and excluded from totals.
Additional holdings last reported Feb 20, 2023, not confirmed since: 51,046 shares. Not included in any total or percentage on this page. Stock options (not counted as shares): Estimate: options held × ($198.00 − strike price), using the most recent insider trade price on Form 4 (Oct 2, 2026), not a market close. Reconciliation: minor difference of 47 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer). |
Frederick Wilson!Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: -10,000 shares on Jun 1, 2026 (Fred and Joanne Wilson 2012 Delaware Trust). See the filing Sales and other transactions for Frederick Wilson are complete. Director | n/a | −95K | n/a | n/a |
Vesting, gifts, unvested awards and holding lines for Frederick Wilson0shares vested or exercised 0gifted (net of own trusts) 0 → 2.8Kunvested awards, start → end Holdings couldn't be fully reconciled. Balance changed without a matching transaction, and the footnote does not state the amount: -10,000 shares on Jun 1, 2026 (Fred and Joanne Wilson 2012 Delaware Trust). The balances below are as reported, not verified totals. |
| Tobias Lutke Director | 222K | 0 | 223K | no sales |
Vesting, gifts, unvested awards and holding lines for Tobias Lutke+1.1Kshares vested or exercised 0gifted (net of own trusts) 1.1K → 2.2Kunvested awards, start → end |
Paul GrewaliMinor difference of 102 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer). Chief Legal Officer | 183K | −16K | 185K | +1.3% |
Vesting, gifts, unvested awards and holding lines for Paul Grewal+37Kshares vested or exercised 0gifted (net of own trusts) −18Kwithheld by the company for taxes 141K → 165Kunvested awards, start → end Stock options (not counted as shares): Estimate: options held × ($198.00 − strike price), using the most recent insider trade price on Form 4 (Oct 2, 2026), not a market close. Reconciliation: minor difference of 102 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer). |
| Alesia Haas Chief Financial Officer | 94K | −472K | 345K | not meaningful |
Vesting, gifts, unvested awards and holding lines for Alesia Haas+132Kshares vested or exercised 0gifted (net of own trusts) −27Kwithheld by the company for taxes 141K → 169Kunvested awards, start → end |
Lawrence BrockiMinor difference of 39 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer). Chief People Officer | 42K | −17K | 42K | not meaningful |
Vesting, gifts, unvested awards and holding lines for Lawrence Brock+29Kshares vested or exercised 0gifted (net of own trusts) −12Kwithheld by the company for taxes 101K → 127Kunvested awards, start → end Stock options (not counted as shares): Estimate: options held × ($198.00 − strike price), using the most recent insider trade price on Form 4 (Oct 2, 2026), not a market close. Reconciliation: minor difference of 39 shares. Difference is stated in footnotes (unreported vesting, exempt acquisition or transfer). |
| Kelly Kramer Director | 34K | 0 | 35K | no sales |
Vesting, gifts, unvested awards and holding lines for Kelly Kramer+1.3Kshares vested or exercised 0gifted (net of own trusts) 1.3K → 2.7Kunvested awards, start → end |
| Christa Davies Director | 19K | 0 | 21K | no sales |
Vesting, gifts, unvested awards and holding lines for Christa Davies+1.9Kshares vested or exercised 0gifted (net of own trusts) −145withheld by the company for taxes 2.7K → 3.1Kunvested awards, start → end |
| Gokul Rajaram Director | 11K | 0 | 12K | no sales |
Vesting, gifts, unvested awards and holding lines for Gokul Rajaram+1.2Kshares vested or exercised 0gifted (net of own trusts) 1.2K → 2.5Kunvested awards, start → end |
| Paul Clement Director | 2K | 0 | 3.9K | no sales |
Vesting, gifts, unvested awards and holding lines for Paul Clement+1.9Kshares vested or exercised 0gifted (net of own trusts) 2.7K → 748unvested awards, start → end |
| Chris Lehane Director | 1.9K | 0 | 3.8K | no sales |
Vesting, gifts, unvested awards and holding lines for Chris Lehane+1.8Kshares vested or exercised 0gifted (net of own trusts) 2.6K → 3Kunvested awards, start → end |
| Jennifer Jones Chief Accounting Officer | 0 | −7.9K | 0 | not meaningful |
Vesting, gifts, unvested awards and holding lines for Jennifer Jones+17Kshares vested or exercised 0gifted (net of own trusts) −9.1Kwithheld by the company for taxes 51K → 59Kunvested awards, start → end Stock options (not counted as shares): Estimate: options held × ($198.00 − strike price), using the most recent insider trade price on Form 4 (Oct 2, 2026), not a market close. |